Product Highlight - Ferinject
09 Dec 2020
Presentation: Each 10 mL vial contains 500 mg of iron as ferric carboxymaltose.
Indication: Ferinject is indicated for treatment of iron deficiency when oral iron preparations are ineffective or cannot be used. The diagnosis of iron deficiency must be based on laboratory tests.
Dosage & Administration: The individual iron need for repletion using Ferinject is determined based on the patient’s body weight and haemoglobin (Hb) level.
| Hb | Patient body weight | |||
| g/dl | mmol/L | below 35 kg | 35 kg to <70 kg | 70 kg and above |
| <10 | <6.2 | 500 mg | 1,500 mg | 2,000 mg |
| 10 to <14 | 6.2 to <8.7 | 500 mg | 1,000 mg | 1,500 mg |
| ≥14 | ≥8.7 | 500 mg | 500 mg | 500 mg |
The maximum recommended cumulative dose of Ferinject is 1,000 mg of iron (20 mL Ferinject) per week.
Reference:
Ferinject Product information: FDA Thailand approval, April 2020
Zuellig Pharma Ltd
8-9 Fl, Ploenchit Center, 2 Sukhumvit Rd, Kwaeng Klongtoey,
Khet Klongtoey, Bangkok 10110
Tel: (+66) 2656 9800 • Fax: (+66) 2342 3433
